GHRHR and cancer: Recently developed peptide antagonists of GHRH-R inhibit the growth of various cancer cell lines and have pre-clinical benefits against prostate cancer, inhibit human gastric cancer, induce apoptosis in retinoblastoma cells and suppress the growth of human malignant melanoma.